Concept information
Preferred term
Spartéine
Type
-
mesh:Descriptor
Broader concept
Entry terms
- 14703-10-7 (unspecified HI(7R-(7alpha,7aalpha,14alpha,14abeta))-isomer)
- 24915-04-6
- 298897D62S
- 299-39-8 (sulfate[1:1](7S-(7alpha,7aalpha,14alpha,14abeta))-isomer)
- 3599-17-5 (mono-HCl(7R-(7alpha,7aalpha,14alpha,14abeta))-isomer)
- 3D76XVF9R0
- 42808-46-8 (unspecified HCl(7R-(7alpha,7aalpha,14alpha,14abeta))-isomer)
- 446-95-7 ((7S-(7alpha,7aalpha,14alpha,14aalpha))-isomer)
- 492-06-8 ((7R-(7alpha,7abeta,14alpha,14abeta))-isomer)
- 492-08-0
- 51799-26-9 (mono-HI(7R-(7alpha,7aalpha,14alpha,14abeta))-isomer)
- 52670-59-4 (sulfate[1:1](7S-(7alpha,7aalpha,14alpha,14aalpha))-isomer)
- 6160-12-9 (sulfate[1:1].pentahydrate((7S-(7alpha,7aalpha,14alpha,14abeta))-isomer))
- 7,14-Methano-2H,6H-dipyrido(1,2-a:1',2'-e)(1,5)diazocine, dodecahydro-, (7S-(7alpha,7aalpha,14alpha,14abeta))-
- 72198-25-5 (unspecified HCl(7S-(7alpha,7aalpha,14alpha,14abeta))-isomer)
- 90-39-1 (Sparteine)
- GQ3J2TLZ7E
- L-Spartéine
Allowable Qualifier(s)
- administration et posologie (Qualificatif)
- agonistes (Qualificatif)
- analogues et dérivés (Qualificatif)
- analyse (Qualificatif)
- antagonistes et inhibiteurs (Qualificatif)
- biosynthèse (Qualificatif)
- classification (Qualificatif)
- composition chimique (Qualificatif)
- économie (Qualificatif)
- effets des radiations (Qualificatif)
- effets indésirables (Qualificatif)
- génétique (Qualificatif)
- histoire (Qualificatif)
- immunologie (Qualificatif)
- intoxication (Qualificatif)
- isolement et purification (Qualificatif)
- liquide cérébrospinal (Qualificatif)
- métabolisme (Qualificatif)
- normes (Qualificatif)
- pharmacocinétique (Qualificatif)
- pharmacologie (Qualificatif)
- physiologie (Qualificatif)
- ressources et distribution (Qualificatif)
- sang (Qualificatif)
- synthèse chimique (Qualificatif)
- toxicité (Qualificatif)
- urine (Qualificatif)
- usage thérapeutique (Qualificatif)
Pharmacological Action(s)
In other languages
-
English
-
14703-10-7 (unspecified HI(7R-(7alpha,7aalpha,14alpha,14abeta))-isomer)
-
24915-04-6
-
298897D62S
-
299-39-8 (sulfate[1:1](7S-(7alpha,7aalpha,14alpha,14abeta))-isomer)
-
3599-17-5 (mono-HCl(7R-(7alpha,7aalpha,14alpha,14abeta))-isomer)
-
3D76XVF9R0
-
42808-46-8 (unspecified HCl(7R-(7alpha,7aalpha,14alpha,14abeta))-isomer)
-
446-95-7 ((7S-(7alpha,7aalpha,14alpha,14aalpha))-isomer)
-
492-06-8 ((7R-(7alpha,7abeta,14alpha,14abeta))-isomer)
-
492-08-0
-
51799-26-9 (mono-HI(7R-(7alpha,7aalpha,14alpha,14abeta))-isomer)
-
52670-59-4 (sulfate[1:1](7S-(7alpha,7aalpha,14alpha,14aalpha))-isomer)
-
6160-12-9 (sulfate[1:1].pentahydrate((7S-(7alpha,7aalpha,14alpha,14abeta))-isomer))
-
7,14-Methano-2H,6H-dipyrido(1,2-a:1',2'-e)(1,5)diazocine, dodecahydro-, (7S-(7alpha,7aalpha,14alpha,14abeta))-
-
72198-25-5 (unspecified HCl(7S-(7alpha,7aalpha,14alpha,14abeta))-isomer)
-
90-39-1 (Sparteine)
-
GQ3J2TLZ7E
-
L-Sparteine
-
Sparteine, (-)-Isomer
-
Sparteine, (7S-(7alpha,7aalpha,14alpha,14abeta))-Isomer
URI
http://data.loterre.fr/ark:/67375/JVR-P01MJBG5-L
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}